Experienced in Metabolic Syndrome

Daniel J. Drucker

St Josef Hospital, 
Bochum, NW, DE 
Experienced in Metabolic Syndrome
St Josef Hospital, 
Bochum, NW, DE 
OverviewLocationsClinical Research

Overview

Daniel Drucker practices in Bochum, Germany. Mr. Drucker is rated as an Experienced expert by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Obesity, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sleeve Gastrectomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 219 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Metabolic Syndrome.

Gender
Male

Locations

St Josef Hospital, Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effects of DPP-4 Inhibitor Therapy on Renal Sodium Handling and Renal Hemodynamics in Type 2 Diabetes Patients. The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
Effects of DPP-4 Inhibitor Therapy on Renal Sodium Handling and Renal Hemodynamics in Type 2 Diabetes Patients. The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug, Other
Study Phase: Phase 4
Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Enrollment Status: Withdrawn
Publish Date: July 17, 2017
Intervention Type: Other, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

219 Total Publications

Loss of GLP-2R signaling in Glp2r-/- mice increases the long-term severity of graft versus host disease.
Loss of GLP-2R signaling in Glp2r-/- mice increases the long-term severity of graft versus host disease.
Journal: Molecular metabolism
Published: November 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Drucker's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile